• News
  • SAN DIEGO
  • BioTech

Novartis to Open Data on Newly Approved Medicines to Researchers

Feb. 26 (Bloomberg) -- Novartis AG will join companies such as GlaxoSmithKline Plc in allowing researchers access to clinical trial data, as regulators demand more transparency.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!